Why the study?
Does a triple-lumen balloon catheter prevent severe systemic hypotension and bradycardia in patients undergoing percutaneous pulmonary valvuloplasty?
Does a triple-lumen balloon catheter prevent severe systemic hypotension and bradycardia in patients undergoing percutaneous pulmonary valvuloplasty?
A novel triple-lumen balloon catheter for pulmonary valvuloplasty appears to prevent severe bradycardia and hypotension by preserving forward blood flow during inflation.
May avoid severe hypotension in valvuloplasty; hypothesis-generating and should not change practice.
Percutaneous transluminal balloon pulmonary valvuloplasty has been performed since 1982. In publications, the most critical problems mentioned are severe systemic hypotension and bradycardia due to stasis of blood flow. A triple-lumen balloon was developed to allow more rapid inflation and deflation and to preserve the preexistent forward blood flow during maximal inflation. Only a slight systemic hypotension and no bradycardia were seen in the first two patients with pulmonary valve stenosis treated with this type of balloon. Thus, the maximal inflation time is not a critical parameter, whereas with the former types of balloon, maximal inflation times were critical, and, if longer than 5 to 10 sec, severe systemic hypotension was registered. We conclude that the triple-lumen pulmonary valve-dilatation balloon catheter is superior to the single-lumen balloon catheter used up to now.
No takes yet. Share an insight, caveat, or question.
Berg et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: